PODD

Insulet Corporation
NASDAQHEALTHCAREMEDICAL DEVICES

Key Statistics

Market Cap
$9.69B
P/E Ratio
26.21
EPS
$5.33
Beta
1.09
52W High
$354.88
52W Low
$126.40
50-Day MA
$154.99
200-Day MA
$223.41
Dividend Yield
Profit Margin
12.30%
Forward P/E
23.70
PEG Ratio
1.44

About Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$3.05B
Gross Profit (TTM)$2.17B
EBITDA$614.90M
Operating Margin16.20%
Return on Equity26.00%
Return on Assets9.72%
Revenue/Share (TTM)$43.62
Book Value$20.51
Price-to-Book6.99
Price-to-Sales (TTM)3.17
EV/Revenue3.391
EV/EBITDA15.86
Quarterly Earnings Growth (YoY)328.60%
Quarterly Revenue Growth (YoY)23.50%
Shares Outstanding$69.35M
Float$69.06M
% Insiders0.33%
% Institutions107.01%

Historical Volatility

HV 10-Day
119.06%
HV 20-Day
87.17%
HV 30-Day
72.96%
HV 60-Day
61.71%
HV Rank
96.8%

Volatility is currently expanding

Analyst Ratings

Consensus ($171.91 target)
5
Strong Buy
16
Buy
4
Hold

Latest News

INSULET DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Insulet Corporation Investors to Secure Counsel Before Important August 31 Deadline in Securities Class Action - PODD

New York, New York--(Newsfile Corp. - August 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and May 26, 2026, inclusive (the "Class Period"), of the important August 31, 2026 lead plaintiff deadline. SO WHAT: If you purchased Insulet securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Newsfile Corp8/18/2026Neutral
Pomerantz Law Firm Announces the Filing of a Class Action Against Insulet Corporation and Certain Officers – PODD

NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) and certain officers. The class action, filed in the United States District Court for the District of Massachusetts, and docketed under 26-cv-13062, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Insulet securities between February 21, 2025 and May 26, 2026, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

GlobeNewsWire8/18/2026Neutral
PODD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Insulet To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Insulet between February 21, 2025 and May 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - August 18, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Insulet Corporation ("Insulet" or the "Company") (NASDAQ: PODD) and reminds investors of the August 31, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Newsfile Corp8/18/2026Neutral
AUGUST 31, 2026 INVESTOR DEADLINE: Insulet Corporation (PODD) Investors with Substantial Losses Have Opportunity to Lead the Insulet Class Action Lawsuit Before August 31, 2026 Deadline - RGRD Law

SAN DIEGO, Aug. 18, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026, inclusive (the “Class Period”), have until August 31, 2026 to seek appointment as lead plaintiff of the Insulet class action lawsuit. Captioned Hu v.

GlobeNewsWire8/18/2026Neutral
Insulet Deadline: PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit

NEW YORK, Aug. 17, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and May 26, 2026, inclusive (the "Class Period"), of the important August 31, 2026 lead plaintiff deadline.  So what: If you purchased Insulet securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

PRNewsWire8/18/2026Neutral
2 WEEK INVESTOR DEADLINE: Insulet Corporation Investors with Substantial Losses Have Opportunity to Lead the Insulet Class Action Lawsuit Before August 31, 2026 Deadline - PODD

SAN DIEGO, Aug. 17, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP  announces that purchasers or acquirers of Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026, inclusive (the "Class Period"), have until August 31, 2026 to seek appointment as lead plaintiff of the Insulet class action lawsuit. Captioned Hu v.

PRNewsWire8/18/2026Neutral
Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Insulet Corporation (NASDAQ: PODD) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Insulet securities between May 21, 2025 and May 26, 2026, both dates inclusive (the “Class Period”).

GlobeNewsWire8/17/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on PODD and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 8/18/2026